Working globally to develop & advance the abilities of #Emory, US, and non-US researchers to engage in world-class research in #diabetes and other related NCDs.
Do individual #GLP1 regimens differ in lower-limb vascular outcomes in #Type2Diabetes? 🩺
A new network meta-analysis coauthored by #EGDRC & @EmoryMedicine’s Dr. Guillermo Umpierrez analyzes RCTs across limb endpoints: https://t.co/FvaAgxRkYU
#Cardiology#ClinicalResearch
#GLP1s have transformed care, but health insurance disparities leave too many patients behind.
#EGDRC’s Dr. Mohammed K. Ali examines the cost, coverage, and equity barriers surrounding GLP-1 access in the latest @EmoryRollins Magazine.
Read here: https://t.co/olqZWwi0A3
A new publication co-authored by EGDRC researchers shows capability, opportunity, and motivation constraints are the biggest barriers to diabetes screenings.
How can we ensure our providers are able to care for our patients? Share your thoughts below!
#EGDRC#DiabetesResearch
Explore the science of Nutritional Metabolomics in a EGDRC Seminar presentation by Jessica A. Alvarez, PhD, RD, Associate Professor of Medicine in the Division of Endocrinology, Metabolism & Lipids at Emory University School of @EmoryDeptofMed.
https://t.co/dlnTckxeEl
In a recent report, the EGDRC sheds light on patients’ self-efficacy and social support levels on their glycemic control.
Dive deeper and view the study: https://t.co/PV7k5bKRDc
#EGDRC#EmorySchoolOfMedicine#EmoryResearch#DiabetesResearch
New insights from EGDRC’s Dr. Rodolfo Galindo and Dr. Guillermo Umpierrez show that Type 2 Diabetes patients taking Farxiga were 9% less likely to face kidney problems than patients taking Invokana.
#EGDRC#EmoryResearch
https://t.co/UGlXtUsKvq
Can prediabetes increase risk of severe COVID?
A new study co-authored by EGDRC’s @felipelobelo found poor glycemic control was linked to more hospitalization and ICU rates. Prediabetes was associated with 43% higher risk of hospitalization.
https://t.co/Ctj43Idjko
#EGDRC
How do we turn evidence into better diabetes care? Join EGDRC for a virtual roundtable this #DiabetesAwarenessMonth! 🔬
📅 Nov 18 | 12:00–1:30 PM ET
💻 Virtual (Zoom)
Explore expert sessions on CGM education, care delivery, and prevention:
https://t.co/dCETGU6sB3
This week, we celebrated @IPaTGT 15th anniversary and welcomed EGDRC Co-Director Dr. @mkali_twindad to its Advisory Board!
We’re proud of our partnership and look forward to continued innovation and collaboration.
#EGDRC#IPaT
🔬 Could tuberculosis increase cardiovascular disease risk?
Emory researcher Dr. Matthew Magee and colleagues found that people with TB had a 3x higher risk of major cardiovascular events.
Learn more: https://t.co/bueUAF6ftu
#Emory#PublicHealth
🔬 Today, #EGDRC welcomed Dr. Jessica A. Alvarez of @EmoryMedicine for a hybrid seminar exploring how #nutritional metabolomics and small molecules can deepen our understanding of #metabolic health.
Thank you, Dr. Alvarez, for sharing your expertise!
Collaboration sparks innovation! 💡
EGDRC recently hosted a Spark Session connecting researchers across nutrition, pediatrics, and diabetes to exchange ideas and explore new partnerships.
Join our research community and check out or upcoming events! https://t.co/yuPVWoc97j
📣TOMORROW: Join us for an evening of storytelling, inspiration and community as EGDRC Executive Director, Dr. Narayan shares the personal story behind his distinguished career at @NRIPulse Stories 2026.
📅 Sept. 26, 2026 | 6:00 PM
📍 Bliss Events & Banquet Hall | Suwanee, GA
📣 Join us for the @arogyaworld Science Symposium this Saturday, bringing together experts in diabetes research, treatment and prevention to explore an important question: Why does diabetes affect South Asians so deeply?
Event Details ⬇️
EGDRC’s Dr. Guillermo Umpierrez was recently featured in AACE’s “Legends in Endocrinology” podcast series. Dr. Umpierrez reflects on his career, the evolution of diabetes care and his contributions to advancing diabetes research and treatment.
🎧: https://t.co/Qpp2zHoa5c
🎉 Congratulations to Daniel Enrique Jimenez, PhD, Associate Professor at the @univmiami Miller School of Medicine, on his newly funded NIH R01! His grant focuses on using health promotion to reduce #cardiometabolic risk in older adults with #HIV.
🫀Cardiovascular risk varies by region.
New research coauthored by Dr. @rodrigoc_90 introduces SCORE2-LAC, a model designed to estimate 10-year CVD risk across Latin America & the Caribbean highlighting why region-specific risk assessment matters.
GCDTR’s Dr. Ashby Walker will co-lead a new @ufdiabetes initiative supported by #Google to use #AI to improve #diabetes detection, provider training and access to care in rural and underserved communities across Florida.
🔗https://t.co/M00Dfnz3TS
🎙️ New Diabetes Care On Air episode highlights the latest diabetes research, including findings from the CARRS cohort showing that younger age at type 2 diabetes diagnosis is linked to greater risks of mortality and lifetime health loss.
🎧 Listen⬇️
https://t.co/vUjc6LuI7r
A new @NatureMedicine correspondence led by EGDRC’s Felix Teufel introduces the TARGET-DM framework, outlining targeted policy solutions to improve medicine access and close diabetes care gaps, particularly in LMIC.
https://t.co/tUFwCOgeiN